Cardiolipin antibodies (CA) are seen in a subgroup of patients with autoimmune disorders, particularly systemic lupus erythematosus (SLE), who are at risk for vascular thrombosis, thrombocytopenia, cerebral infarct and/or recurrent spontaneous abortion. Elevations of CA associated with increased risk have also been seen in idiopathic thrombocytopenic purpura, rheumatoid and psoriatic arthritis, and primary Sjögren's syndrome.
Rat Anti-cardiolipin IgG antibody (ACA-IgG) ELISA Kit employs the competitive enzyme immunoassay technique. The microtiter plate provided in this kit has been pre-coated with an antibody specific to ACA-IgG. Standards or samples are then added to the appropriate microtiter plate wells with a Horseradish Peroxidase (HRP)-conjugated ACA-IgG and incubated. The competitive inhibition reaction is launched between with HRP labeled ACA-IgG and unlabeled ACA-IgG with the antibody. A substrate solution is added to the wells and the color develops in opposite to the amount of ACA-IgG in the sample. The color development is stopped and the intensity of the color is measured.
Rat Anti-cardiolipin IgG antibody (ACA-IgG) ELISA Kit listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.
Find more details at http://www.abbkine.com/product/rat-anti-cardiolipin-igg-antibody-aca-igg-elisa-kit-kte100923/
bio-equip.cn
中文
